Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Calgary

$70,000.00

Characterization and germ line differentiation of non-rodent embryonic stem cells

EF 2012-13

Résumé
The milk of transgenic dairy animals is a valuable source of complex recombinant, biopharmaceutical proteins that is safer and requires lower capital investment than traditional bioreactors. The current state of the art for generating transgenic farm animals is somatic cell nuclear transfer (SCNT), which is inefficient and expensive. Recently, we developed germ cell transplantation (GCT) as a novel, potentially more efficient alternative for the production of transgenic large animals. Availability of cell lines that can be modified and characterized before use for SCNT or GCT would substantially improve efficiency and commercial viability of transgenic animals for recombinant protein production. Objectives of this project are to derive stem cells from goat embryos and to study differentiation of these cells into male germ cells. The goat is of significant commercial interest for recombinant protein production. The goat also is an ideal large-animal model for studying germ lineage differentiation because embryogenesis, SCNT and embryo transfer are well understood, and we have developed transplantation assays for germ line differentiation in this species. We recently derived a goat embryonic stem cell line. Here, we will test the hypothesis that cell lines derived from goat embryos can differentiate into all tissue types of the body (a hallmark characteristic of embryonic stem cells). We will then use animal models developed by us to measure differentiation of embryo-derived stem cells to functional male germ cells that produce sperm. These studies will test the hypothesis that exposure to the testis environment will induce germ cell differentiation. Finally, we will test the hypothesis that stem cells present in the testis can revert to undifferentiated stem cells resembling those derived from the embryo. The expected impact of this project is to establish a large animal model for deriving functional male germ cells from embryonic stem cells. Availability of embryo- or germ cell derived stem cells is expected to translate into more efficient ways to generate transgenic large animals for large scale production of recombinant proteins. Importantly, this program will provide an ideal training environment for highly qualified individuals for academia and biotech industry.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
385837-2010
Name nom
Dobrinski, Ina
Department département
Veterinary Medicine, Faculty of
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2010
Award amount
70000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5505
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal reproduction
Research subject fr
Reproduction animale
Partie
3
Nb partie
5
Application title
Characterization and germ line differentiation of non-rodent embryonic stem cells
Keyword
NSERC
Application summary
The milk of transgenic dairy animals is a valuable source of complex recombinant, biopharmaceutical proteins that is safer and requires lower capital investment than traditional bioreactors. The current state of the art for generating transgenic farm animals is somatic cell nuclear transfer (SCNT), which is inefficient and expensive. Recently, we developed germ cell transplantation (GCT) as a novel, potentially more efficient alternative for the production of transgenic large animals. Availability of cell lines that can be modified and characterized before use for SCNT or GCT would substantially improve efficiency and commercial viability of transgenic animals for recombinant protein production. Objectives of this project are to derive stem cells from goat embryos and to study differentiation of these cells into male germ cells. The goat is of significant commercial interest for recombinant protein production. The goat also is an ideal large-animal model for studying germ lineage differentiation because embryogenesis, SCNT and embryo transfer are well understood, and we have developed transplantation assays for germ line differentiation in this species. We recently derived a goat embryonic stem cell line. Here, we will test the hypothesis that cell lines derived from goat embryos can differentiate into all tissue types of the body (a hallmark characteristic of embryonic stem cells). We will then use animal models developed by us to measure differentiation of embryo-derived stem cells to functional male germ cells that produce sperm. These studies will test the hypothesis that exposure to the testis environment will induce germ cell differentiation. Finally, we will test the hypothesis that stem cells present in the testis can revert to undifferentiated stem cells resembling those derived from the embryo. The expected impact of this project is to establish a large animal model for deriving functional male germ cells from embryonic stem cells. Availability of embryo- or germ cell derived stem cells is expected to translate into more efficient ways to generate transgenic large animals for large scale production of recombinant proteins. Importantly, this program will provide an ideal training environment for highly qualified individuals for academia and biotech industry.